SiriusPoint saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 70 to 73.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's proprietary RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the last 52 weeks compares to other publicly traded companies.
History reveals that the top-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves. See if SiriusPoint can continue to rebound and clear that threshold.
SiriusPoint is trying to complete a consolidation with a 21.03 buy point. See if the stock can clear the breakout price in heavy trading. Keep in mind that it's a later-stage consolidation, and those are riskier than earlier-stage patterns.
SiriusPoint posted -12% earnings growth in its most recent report, while sales growth came in at 1%.
SiriusPoint earns the No. 44 rank among its peers in the Insurance-Property/Casualty/Title industry group. Amer Integrity Ins, HCI Group and Heritage Insurance are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
